Submit the U.S. BLA for beti-cel
Delivered after the deadline
AI-confirmed · human review in progress Independent AI checks agreed on primary SEC or regulator evidence. Records are now being reviewed by hand, starting with those our customers order.
- Announced
- 11 Jan 2021
- Due
- 30 Jun 2021
- Delivered
- September 2021
- Deadline
- Met
- Late
- Not met
- Today
What the company said
“beti-cel U.S. BLA submission (mid-year)”
What we found
Evidence strength A What the grades mean
The company missed its mid-year 2021 deadline, subsequently updating its expectation to the third quarter of 2021 and completing the BLA submission in September 2021.
-
A bluebird bio, Inc. 10-Q filed 2021-08-09
“We currently expect to complete our BLA submission for beti-cel in the third quarter of 2021” ✓ confirmed on the page
-
A bluebird bio, Inc. 10-Q filed 2021-11-05
“In September 2021, we completed the submission of our BLA to the FDA for beti-cel” ✓ confirmed on the page
Checked 24 Oct 2026.
Commitment DNA
The structured record of this commitment. Fields the company did not state are left blank rather than guessed.
- Event type
- Regulatory submission
- Indicative materiality
- High rules
- Action
- Submit
- Deliverable
- beti-cel U.S. BLA
- Where
- U.S.
- In the company’s control
- High
- Specificity
- High
- Depends on
- Regulatory
How this entry was checked
- Commitment recordedThe company's words were matched word for word against the filing.
- First checkAn AI model, Gemini (Google), read the company's later filings and recorded the outcome with a quoted passage.
- Second check: agreesA different AI model, Claude (Anthropic), re-read the evidence without being told the outcome and reached the same answer.
Confirmed. This outcome counts towards the company's Kept Score. How verification works
Are you bluebird bio, Inc.? You can publish an official statement next to this entry, free. Add a statement.
Is something here wrong or out of date? Companies and readers can ask us to check it. Please bring a link to a public source.
Report an error in this entry Reference: KI-C-2021-C293971-021693 · Corrections policy